Európska únia -
rumunčina -
EMA (European Medicines Agency)
maviret
abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatita c, cronică - antivirale pentru uz sistemic - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.
Moldavsko -
rumunčina -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
norvir 100 mg comprimate filmate
abbvie deutschland gmbh & co.kg - ritonavirum - comprimate filmate - 100 mg
Moldavsko -
rumunčina -
AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)
synagis 100 mg/ml soluţie injectabilă
abbvie deutschland gmbh & co.kg - palivizumabum - soluţie injectabilă - 100 mg/ml
Európska únia -
rumunčina -
EMA (European Medicines Agency)
skyrizi
abbvie deutschland gmbh & co. kg - risankizumab - psoriasis; arthritis, psoriatic - imunosupresoare - plaque psoriasisskyrizi is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritisskyrizi, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adults who have had an inadequate response or who have been intolerant to one or more disease-modifying antirheumatic drugs (dmards). crohn's diseaseskyrizi is indicated for the treatment of adult patients with moderately to severely active crohn's disease who have had an inadequate response to, lost response to, or were intolerant to conventional therapy or a biologic therapy.
Európska únia -
rumunčina -
EMA (European Medicines Agency)
aquipta
abbvie deutschland gmbh & co. kg - atogepant - tulburări ale migrenei - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.
Európska únia -
rumunčina -
EMA (European Medicines Agency)
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - agenți antineoplazici - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
